X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1188) 1188
Publication (77) 77
Book Review (31) 31
Book Chapter (15) 15
Book / eBook (3) 3
Conference Proceeding (2) 2
Dissertation (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (731) 731
index medicus (485) 485
oncology (462) 462
female (428) 428
male (411) 411
chemotherapy (410) 410
intrathecal chemotherapy (361) 361
injections, spinal (291) 291
cancer (277) 277
adult (239) 239
clinical neurology (233) 233
methotrexate (232) 232
middle aged (227) 227
child (224) 224
intrathecal methotrexate (218) 218
hematology (196) 196
adolescent (186) 186
aged (165) 165
children (150) 150
child, preschool (149) 149
intrathecal (149) 149
medicine & public health (148) 148
acute lymphoblastic-leukemia (143) 143
neoplastic meningitis (141) 141
treatment outcome (140) 140
pediatrics (138) 138
cerebrospinal-fluid (137) 137
methotrexate - administration & dosage (135) 135
care and treatment (134) 134
central-nervous-system (125) 125
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (124) 124
therapy (124) 124
antineoplastic combined chemotherapy protocols - therapeutic use (118) 118
animals (117) 117
meningeal carcinomatosis (117) 117
pharmacology & pharmacy (112) 112
neurotoxicity (109) 109
leukemia (108) 108
prognosis (103) 103
radiotherapy (103) 103
central nervous system (99) 99
neurosciences (98) 98
retrospective studies (98) 98
infant (95) 95
antineoplastic agents - therapeutic use (92) 92
antineoplastic agents - administration & dosage (91) 91
pain (89) 89
magnetic resonance imaging (87) 87
breast cancer (84) 84
combined modality therapy (84) 84
risk factors (83) 83
antimetabolites, antineoplastic - administration & dosage (82) 82
metastasis (82) 82
methotrexate - adverse effects (82) 82
cranial irradiation (80) 80
cytarabine - administration & dosage (78) 78
acute lymphocytic-leukemia (77) 77
meningitis (76) 76
acute lymphoblastic leukemia (75) 75
surgery (75) 75
drug therapy (74) 74
analysis (73) 73
cancer pain (73) 73
meningeal neoplasms - drug therapy (73) 73
management (70) 70
survival (69) 69
health aspects (68) 68
diagnosis (66) 66
high-dose methotrexate (66) 66
leptomeningeal metastases (65) 65
solid tumors (65) 65
cerebrospinal fluid (63) 63
research (63) 63
meningeal neoplasms - secondary (62) 62
antineoplastic agents - adverse effects (60) 60
neurology (60) 60
rituximab (59) 59
antineoplastic combined chemotherapy protocols - adverse effects (58) 58
non-hodgkins-lymphoma (57) 57
cytarabine (55) 55
recurrence (55) 55
brain (54) 54
methotrexate - therapeutic use (53) 53
antimetabolites, antineoplastic - adverse effects (52) 52
antineoplastic combined chemotherapy protocols - administration & dosage (52) 52
leptomeningeal carcinomatosis (52) 52
aged, 80 and over (51) 51
brain neoplasms - drug therapy (51) 51
leptomeningeal metastasis (51) 51
prognostic-factors (51) 51
anesthesiology (50) 50
lymphoma (50) 50
follow-up studies (49) 49
intrathecal therapy (49) 49
relapse (49) 49
young adult (49) 49
medicine, general & internal (48) 48
morphine (48) 48
lymphomas (47) 47
breast-cancer (46) 46
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1124) 1124
French (24) 24
German (24) 24
Japanese (14) 14
Russian (5) 5
Spanish (5) 5
Chinese (4) 4
Korean (4) 4
Polish (4) 4
Czech (3) 3
Hungarian (3) 3
Turkish (2) 2
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 1/2012, Volume 106, Issue 1, pp. 143 - 146
The role of prophylactic intrathecal chemotherapy in the treatment of primary central nervous system lymphoma remains controversial. We report a retrospective... 
Prophylactic intrathecal chemotherapy | Neurology | Oncology | PCNSL | Neurotoxicity | Medicine & Public Health | DEFERRED RADIOTHERAPY | HIGH-DOSE METHOTREXATE | TUMOR | OLDER | PHASE-II | INITIAL TREATMENT | CLINICAL NEUROLOGY | PILOT | THERAPY | ONCOLOGY | NERVOUS-SYSTEM LYMPHOMA | Procarbazine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Young Adult | Lymphoma - drug therapy | Karnofsky Performance Status | Aged, 80 and over | Adult | Female | Retrospective Studies | Neuroprotective Agents - administration & dosage | Injections, Spinal | Neoplasm Recurrence, Local - prevention & control | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Aged | Central Nervous System Neoplasms - drug therapy | Lomustine - administration & dosage | Cohort Studies | Methylprednisolone - administration & dosage | Chemotherapy | Clouds | Analysis | Methylprednisolone | Methotrexate | Hydrocortisone | Drug therapy | Cancer | cytarabine | Intravenous administration | Central nervous system | Prophylaxis | methylprednisolone | Disease control | Lymphoma | Survival | procarbazine | Age
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 12/2018, Volume 65, Issue 12, pp. e27385 - n/a
Patients with retinoblastoma and central nervous system (CNS) involvement are rarely curable with available treatments. We designed a high‐dose intra‐arterial... 
intrathecal topotecan | metastatic retinoblastoma | intra‐arterial chemotherapy | intra-arterial chemotherapy | ANGIOGRAPHY | CLINICAL-TRIAL | ONCOLOGY | TOPOTECAN | PEDIATRICS | HEMATOLOGY | BRAIN-TUMORS | DELIVERY | CHILDREN | Care and treatment | Chemotherapy | Retinoblastoma | Cancer | Central nervous system | Melphalan | Bone marrow | Carboplatin | Topotecan | Cerebrospinal fluid | Patients
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 02/2017, Volume 92, Issue 2, pp. 155 - 160
Journal Article
Molecular and Cellular Neuroscience, ISSN 1044-7431, 01/2018, Volume 86, pp. 65 - 71
Doxorubicin, a commonly used anti-neoplastic agent, causes severe neurotoxicity. Doxorubicin promotes thinning of the brain cortex and accelerates brain aging,... 
Brain aging | Chemotherapy | Peroxisomes | Doxorubicin | NETWORK | CYCLODEXTRIN | COGNITIVE IMPAIRMENT | MECHANISMS | NEUROSCIENCES | MOUSE MODELS | BREAST-CANCER | RAT-LIVER PEROXISOMES | INTRATHECAL METHOTREXATE | INDUCED NEURODEGENERATION | PERIPHERAL NEUROPATHY | Oxidative stress | Brain | Anthracyclines | Neurons | Cyclodextrins | Genetic transcription | Cancer | Neurophysiology | Index Medicus
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 04/2015, Volume 122, Issue 2, pp. 391 - 398
Methotrexate and cytarabine arabinoside are frequently administered intrathecally in the prophylaxis and treatment of patients with hematological malignancies.... 
Myelopathy | Intrathecal chemotherapy | Lymphoid leukemia | Spinal cord dorsal columns T2 hyperintensity | SURVIVAL | CYTOSINE-ARABINOSIDE | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | NEUROTOXICITY | CANCER | CLINICAL NEUROLOGY | Spinal Cord - drug effects | Spinal Cord Diseases - physiopathology | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Magnetic Resonance Imaging - methods | Male | Cytarabine - adverse effects | Antimetabolites, Antineoplastic - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Spinal Cord - pathology | Adult | Female | Leukemia, B-Cell - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications | Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications | Myelin Basic Protein - metabolism | Leukemia, B-Cell - complications | Cytarabine - administration & dosage | Methotrexate - adverse effects | Spinal Cord Diseases - chemically induced | Adolescent | Antimetabolites, Antineoplastic - adverse effects | Methotrexate - administration & dosage | Aged | Spinal Cord Diseases - pathology | Injections, Spinal - adverse effects | Chemotherapy | Metabolites | Leukemia | Adults | Methotrexate | Folic acid | Myelin proteins | Cancer | spinal cord dorsal columns T2 hyperintensity | intrathecal chemotherapy | lymphoid leukemia | myelopathy
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2010, Volume 79, Issue 2, pp. 127 - 134
Abstract Central Nervous System (CNS) involvement in lymphoma can occur whether at diagnosis or, more often, at the progression or recurrence of disease and... 
Hematology, Oncology and Palliative Medicine | Meningeal | Hodgkin | Lymphomatous meningitis | Lymphoma | Intrathecal | Central nervous system | NERVOUS-SYSTEM INVOLVEMENT | RISK-FACTORS | BONE-MARROW-TRANSPLANTATION | HIGH-DOSE METHOTREXATE | ACUTE LYMPHOCYTIC-LEUKEMIA | B-CELL LYMPHOMAS | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | NON-HODGKINS-LYMPHOMA | OF-THE-LITERATURE | HEMATOLOGY | LIPOSOMAL CYTARABINE | Lymphoma, Non-Hodgkin - immunology | Recurrence | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Lymphoma, Non-Hodgkin - pathology | Central Nervous System Neoplasms - secondary | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Immunocompetence | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Doxorubicin - administration & dosage | Lymphoma, Non-Hodgkin - drug therapy | Prednisone - administration & dosage | Meninges - pathology | Drug Administration Schedule | Risk Factors | Rituximab | Leukemic Infiltration | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Injections, Spinal - methods | Immunocompromised Host | Lymphoma, Non-Hodgkin - diagnosis | Chemotherapy | Relapse | Leukemia | Development and progression | Meningitis | Non-Hodgkin's lymphomas | Cancer | Diseases
Journal Article